---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-006801"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2022-10-07T23:59:59+00:00"
generated_at: "2026-06-23T04:39:40.918524+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sonoma Pharmaceuticals appoints Chad White as CFO, succeeding Jerry Dvonch effective Nov 18, 2022

## Summary
- Jerry Dvonch resigns as CFO effective Nov 18, 2022; will assist transition to Boulder, CO office by Dec 31.
- Chad White appointed interim CFO Oct 3 and permanent CFO Nov 18; previously CFO at Slumber Cloud and Outlast Technologies.
- White receives $230,000 annual salary, bonus up to 50% of salary, and options for 5,000 shares vesting over 3 years.
- Company closing Woodstock, GA office; operations to be centralized in Boulder, CO.

## SEC filing metadata
- accession: 0001683168-22-006801
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2022-10-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/0001683168-22-006801-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/snoa_i8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-006801
- JSON: https://secwatch.observer/filing/0001683168-22-006801.json
- Plain text: https://secwatch.observer/filing/0001683168-22-006801.txt

## Key facts
- Executive change
  Chad White was appointed as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Effective on October 3, 2022, our Board of Directors appointed Chad White as our interim Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/0001683168-22-006801-index.htm
- Executive change
  Jerry Dvonch resigned as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: We accepted the resignation of Mr. Dvonch as Chief Financial Officer effective November 18, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/0001683168-22-006801-index.htm
- Executive change
  Chad White changed role as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..
  - Role: Chief Financial Officer
  source text: Effective November 18, 2022, Mr. White will serve as Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/0001683168-22-006801-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.